NBC/screenshot
"Today is a miraculous day," Kent Brantly told reporters. "I am thrilled to be alive, to be well, and to be reunited with my family."
Brantly was given ZMapp, a drug developed by U.S.-based Mapp Biopharmaceutical and used on a handful of patients in the West African outbreak.
"As a medical missionary, I never imagined myself in this position. When my family and I moved to Libera … Ebola was not on the radar," Brantly said. "We moved to Liberia because God called us to serve the people in Liberia.
"In March … we began preparing for the worst. We received the first Ebola patient in June. [After] the use of an experimental drug and the expertise of a healthcare team at [Atlanta's Emory Hospital] … God saved my life."
More to come.